The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Prognostic Influence of Increased C-Reactive Protein and Fibrinogen Levels in Ischemic Stroke
Open accessAbstract
Background and Purpose —The prognostic influences of fibrinogen and C-reactive protein (CRP) levels and their relations in ischemic stroke have not been well described. The aim of this study was to investigate and compare the 1-year prognostic influences of fibrinogen and CRP levels on outcome in ischemic stroke. Methods —Fibrinogen and CRP were determined within 24 hours after stroke and related to 1-year outcome in 128 patients with first-ever ischemic stroke. The Kaplan-Meier technique was applied in survival analysis. Multiple logistic regression analysis was used to evaluate the associations between risk factors and outcome. Results —The probabilities of death or new vascular event were 21.1%, 27.9%, and 51.7% ( P =0.0172, χ 2 for trend), respectively, in patients stratified by tertiles of fibrinogen (<3.78, 3.78 to 6.17, and >6.17 g/L). The probabilities of a primary end point were 12.1%, 29.7%, and 54.8% ( P =0.0004), respectively, after stratification of patient data by tertiles of CRP level (<5, 5 to 33, and >33 mg/L). In multiple logistic regression analysis, higher CRP levels (odds ratio, 2.39; 95% CI, 1.28 to 4.49; P =0.0066) and stroke severity on the Canadian Neurological Stroke Scale (odds ratio, 2.37; 95% CI, 1.01 to 5.58; P =0.0472) were independently associated with death or new vascular event. Conclusions —Increased levels of CRP are associated with a worse outcome in patients with ischemic stroke. The increased risk associated with elevated CRP levels is independent of the prognostic influence of fibrinogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional evaluation : Barthel index
Mahonery, F. I. (1965) · Medical Entomology and Zoology · Cited by 12,762
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Pathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943
Classification and natural history of clinically identifiable subtypes of cerebral infarction
Bamford, J., Sandercock, P., Dennis, M., Warlow, C., & Burn, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)93206-o · Cited by 3,294
Dennis, M. S. (1996) · The Lancet · Cited by 2,728
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
The Harvard Cooperative Stroke Registry: A prospective registry
Mohr, J. P., Caplan, L. R., Melski, J. W., Goldstein, R. J., Duncan, G. W., Kistler, J. P., Pessin, M. S., & Bleich, H. L. (1978) · Neurology · doi:10.1212/wnl.28.8.754 · Cited by 1,172
Fibrinogen as a Cardiovascular Risk Factor: A Meta-Analysis and Review of the Literature
Ernst, E., & Resch, K. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-12-199306150-00008 · Cited by 990
The Stroke Data Bank: design, methods, and baseline characteristics.
Foulkes, M. A., Wolf, P. A., Price, T. R., Mohr, J. P., & Hier, D. B. (1988) · Stroke · doi:10.1161/01.str.19.5.547 · Cited by 946
Cited by
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Gan, W. Q. (2004) · Thorax · doi:10.1136/thx.2003.019588 · Cited by 1,838
Emerging Risk Factors for Atherosclerotic Vascular Disease: A Critical Review of the Evidence
Hackam, D. G., & Anand, S. S. (2003) · JAMA · doi:10.1001/jama.290.7.932 · Cited by 550
Smith, C. J., Emsley, H. C., Gavin, C. M., Georgiou, R. F., Vail, A., Barberan, E. M., del Zoppo, G. J., Hallenbeck, J. M., Rothwell, N. J., Hopkins, S. J., et al. (2004) · BMC Neurology · doi:10.1186/1471-2377-4-2 · Cited by 480
Kuo, H.-K., Yen, C.-J., Chang, C.-H., Kuo, C.-K., Chen, J.-H., & Sorond, F. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70099-5 · Cited by 399
Myers, G. L., Rifai, N., Tracy, R. P., Roberts, W. L., Alexander, R. W., Biasucci, L. M., Catravas, J. D., Cole, T. G., Cooper, G. R., Khan, B. V., et al. (2004) · Circulation · doi:10.1161/01.cir.0000148980.87579.5e · Cited by 391
What Does Minor Elevation of C-Reactive Protein Signify?
Kushner, I., Rzewnicki, D., & Samols, D. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.057 · Cited by 372
Di Napoli, M., Schwaninger, M., Cappelli, R., Ceccarelli, E., Di Gianfilippo, G., Donati, C., Emsley, H. C. A., Forconi, S., Hopkins, S. J., Masotti, L., et al. (2005) · Stroke · doi:10.1161/01.str.0000165929.78756.ed · Cited by 289
Self-citationInflammation and Infection in Clinical Stroke
Emsley, H. C. A., & Tyrrell, P. J. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200212000-00001 · Cited by 276
Elkind, M. S. V., Tai, W., Coates, K., Paik, M. C., & Sacco, R. L. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2073 · Cited by 255
Mechanisms of C-Reactive Protein-Induced Blood–Brain Barrier Disruption
Kuhlmann, C. R. W., Librizzi, L., Closhen, D., Pflanzner, T., Lessmann, V., Pietrzik, C. U., de Curtis, M., & Luhmann, H. J. (2009) · Stroke · doi:10.1161/strokeaha.108.535930 · Cited by 138
Matsumoto, J., Dohgu, S., Takata, F., Iwao, T., Kimura, I., Tomohiro, M., Aono, K., Kataoka, Y., & Yamauchi, A. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135352 · Cited by 21
Metadata
- Authors
- Di Napoli, M., Papa, F., & Bocola, V.
- Venue
- Stroke
- Published
- 2001-01
- Volume
- 32
- Issue
- 1
- Pages
- 133-138
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2050798863
- Cited by
- 315
- References
- 36
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.